Lungpacer Medical
PrivateLast Round
Convertible Debt
Sep 30, 2026
Total Funding Raised
$128.76M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lungpacer Medical operates in Healthcare & Life Sciences and is based in Exton, Pennsylvania. Its latest recorded funding round was a Growth Equity round in June 2025.
Lungpacer Medical is a medical device company that develops minimally invasive neurostimulation technologies to help critically ill patients wean off mechanical ventilation and restore diaphragm strength.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lungpacer Medical Comparables
Compare Lungpacer Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liberate Medical | 85% | |
| Synapse Biomedical Inc. | 84% | |
| Stimdia Medical | 84% |
For institutional investors. Book with your work email.
Lungpacer Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 30, 2026 | ||||
| Convertible Debt | Apr 23, 2026 | ||||
| Growth Equity | Jun 26, 2025 | ||||
| Convertible Debt | Apr 1, 2025 | ||||
| Grant | May 1, 2023 | ||||
Series B | Apr 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lungpacer Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Defense Health Agency | Grant |
| Keiretsu Forum | Angel |
| New Enterprise Associates | Private Equity |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| Keiretsu Capital | Angel |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2026
Raised $8M in convertible debt.
- Apr 23, 2026
$12M raised in Seed Round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 26, 2026
In Aug '26, Lungpacer Medical Inc. commercializes the FDA-approved AeroPace System at hospitals in the United States to help critically ill patients discontinue mechanical ventilation; its temporary catheter stimulates the phrenic nerves and activates the diaphragm.
- receives_awardAug 19, 2026
Lungpacer Medical Inc.'s AeroPace System is nominated by the Prix Galien Foundation for the 2026 Prix Galien USA Award for Best Medical Technology in Pennsylvania on Aug. 19th '26; winners are honored at the Prix Galien USA Awards Ceremony in October 2026.
For institutional investors. Book with your work email.
Lungpacer Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lungpacer Medical's valuation, stock price, and market status.
Is Lungpacer Medical a public or private company?
Lungpacer Medical is a private company.
What is the current stock price of Lungpacer Medical?
Lungpacer Medical is a private company, so its shares have no public market price. Caplight tracks Lungpacer Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lungpacer Medical worth (valuation)?
Valuation information for Lungpacer Medical is not publicly available.
Can I buy Lungpacer Medical stock?
Lungpacer Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lungpacer Medical's last funding round?
Lungpacer Medical's most recent funding round was Convertible Debt on September 30, 2026.
Who are the main investors in Lungpacer Medical?
Key investors in Lungpacer Medical include Public Health Emergency Medical Countermeasures Enterprise, Biomedical Advanced Research and Development Authority.
Will Lungpacer Medical IPO soon?
No public IPO plans have been announced for Lungpacer Medical.
How can I track Lungpacer Medical secondary market activity?
Caplight tracks bids, offers, and trades in Lungpacer Medical's shares on secondary markets.